Publications by authors named "Shushan Ge"

Claim this Profile
1
1-(3,4-Diaminophenyl)-1H-pyrrole-2-carboxylic acids as potent apo-IDO1 inhibitors exhibiting efficacy in syngeneic tumor mouse models.
Yi Zou, Shushan Ge, Haiqing Zhong, Yingbo Zheng, Xuewei Ma

Eur J Med Chem· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing unsupervised machine learning with [F]FDG PET/CT to develop a composite model for predicting overall survival in cervical cancer patients undergoing concurrent chemoradiotherapy.
Jinyu Shi, Lian Wang, Min Zhou, Shushan Ge, Bin Zhang

Front Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cutting-edge Ga-labeled bicyclic peptide PET molecular probe for noninvasive assessment of Nectin4 expression.
Shushan Ge, Tongtong Jia, Jinyu Shi, Jinming Cao, Shibiao Sang

Bioorg Chem· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating F-FDG PET/CT radiomics and body composition for enhanced prognostic assessment in patients with esophageal cancer.
Yeye Zhou, Jin Zhou, Xiaowei Cai, Shushan Ge, Shibiao Sang

BMC Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of diffuse increased fluorine-18-fluorodeoxyglucose (F-FDG) uptake within the reticuloendothelial system in lymphoma patients.
Zixuan Zhao, Yeye Zhou, Xiaodong Yao, Shushan Ge, Shibiao Sang

Quant Imaging Med Surg· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging and Monitoring HER2 Expression in Tumors during HER2 Antibody-Drug Conjugate Therapy Utilizing a Radiolabeled Site-Specific Single-Domain Antibody Probe: Ga-NODAGA-SNA004-GSC.
Shushan Ge, Chao Wang, Xuyang You, Huihui He, Bin Zhang

J Med Chem· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IDO1 Inhibition Promotes Activation of Tumor-intrinsic STAT3 Pathway and Induces Adverse Tumor-protective Effects.
Longbo Yu, Lingyan Xu, Yunjie Chen, Yicheng Rong, Yi Zou, Shushan Ge

J Immunol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel Ga-labeled cyclic peptide molecular probe based on the computer-aided design for noninvasive imaging of PD-L1 expression in tumors.
Shushan Ge, Bin Zhang, Jihui Li, Jinyu Shi, Tongtong Jia

Bioorg Chem· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Apo-Form Selective Inhibition of IDO for Tumor Immunotherapy.
Wen Liu, Yi Zou, Kaiming Li, Haiqing Zhong, Longbo Yu, Shushan Ge

J Immunol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiomic signatures based on pretreatment 18F-FDG PET/CT, combined with clinicopathological characteristics, as early prognostic biomarkers among patients with invasive breast cancer.
Tongtong Jia, Qingfu Lv, Xiaowei Cai, Shushan Ge, Shibiao Sang

Front Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular imaging of immune checkpoints in oncology: Current and future applications.
Shushan Ge, Tongtong Jia, Jihui Li, Bin Zhang, Shengming Deng

Cancer Lett· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of apatinib with apo-IDO1 inhibitor for the treatment of colorectal cancer.
Longbo Yu, Yuanyuan Wang, Yingxue He, Haiqing Zhong, Shushan Ge

Int Immunopharmacol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of F-FDG PET/CT radiomic model based on primary tumor in patients with non-small cell lung cancer: A large single-center cohort study.
Jihui Li, Bin Zhang, Shushan Ge, Shengming Deng, Chunhong Hu

Front Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apo-Form Selective Inhibition of IDO for Tumor Immunotherapy.
Wen Liu, Yi Zou, Kaiming Li, Haiqing Zhong, Longbo Yu, Shushan Ge

J Immunol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of PD-L1 Expression Level in Patients With Non-Small Cell Lung Cancer by F-FDG PET/CT Radiomics and Clinicopathological Characteristics.
Jihui Li, Shushan Ge, Shibiao Sang, Chunhong Hu, Shengming Deng

Front Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review: Radionuclide Molecular Imaging Targeting HER2 in Breast Cancer with a Focus on Molecular Probes into Clinical Trials and Small Peptides.
Shushan Ge, Jihui Li, Yu Yu, Zhengguo Chen, Yi Yang

Molecules· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of secondary sulphonamides as IDO1 inhibitors with potent antitumour effects .
Shushan Ge, Haiqing Zhong, Xuewei Ma, Yingbo Zheng, Yi Zou

J Enzyme Inhib Med Chem· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective Virtual Screening Strategy toward heme-containing proteins: Identification of novel IDO1 inhibitors.
Yi Zou, Yue Hu, Shushan Ge, Yingbo Zheng, Yuezhen Li

Eur J Med Chem· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excellent antitumor and antimetastatic activities based on novel coumarin/pyrazole oxime hybrids.
Hong Dai, Meiling Huang, Jianqiang Qian, Ji Liu, Chi Meng, Shushan Ge

Eur J Med Chem· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of novel bis-pyrazole derivatives as antitumor agents with potent apoptosis induction effects and DNA damage.
Hong Dai, Shushan Ge, Jing Guo, Shi Chen, Meiling Huang

Eur J Med Chem· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and bioactivities of novel oxadiazole-substituted pyrazole oximes.
Hong Dai, Jia Chen, Gang Li, Shushan Ge, Yujun Shi

Bioorg Med Chem Lett· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and bioactivities of novel pyrazole oxime derivatives containing a 1,2,3-thiadiazole moiety.
Hong Dai, Shushan Ge, Gang Li, Jia Chen, Yujun Shi

Bioorg Med Chem Lett· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological activities of novel 1,3,4-thiadiazole-containing pyrazole oxime derivatives.
Hong Dai, Gang Li, Jia Chen, Yujun Shi, Shushan Ge

Bioorg Med Chem Lett· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis